OBIO CAAP 2016 company, Swift Medical, a market leader in machine vision and machine learning platforms for mobile health and data analytics, today announced completing a rounds of funding led by Montreal's Real Ventures with participation from Relay Ventures, Lumira Capital, MaRS IAF and a strategic partner.
OBIO has partnered with JLABS Toronto to provide access to all JLABS Toronto Events for OBIO Members for FREE!
MaRS Innovation (MI) and its South Korean partner, Korea Health Industry Development Institute (KHIDI), continue to build on the five-year global partnership agreement signed in December 2016 during Premier Wynne’s mission to the Republic of Korea.
OBIO CAAP 2014 company, Intronix Technologies, will be launching their "Myoguide DOC"
OBIO Member company, Steadiwear, wins again!
Former OBIO CAAP companies, Eve Medical and QoC Health, have been quoted in The Globe and Mail this week
OBIO Member, the Centre for the Commercialization of Antibodies and Biologics (CCAB)has signed an Agreement with Pionyr Immunotherapeutics Inc.
OBIO Member, Steadiwear, has won 1st Place in the RESI on MaRS Innovation Challenge.
OBIO CAAP companies, Pathcore and WinterLight Labs have both been announced as recipients of the Ontario Health Technology Fund!
OBIO kicked off its 2017 Capital Access Advisory Program (CAAP®) on March 29, 2017, hosted at sponsor Norton Rose Fulbright LLP (NRF) Canada, just as Toronto’s first inaugural Health Innovation Week launches.